Prostate adenocarcinoma is present in over 80% of men over the age of 80 and is by far the most common cancer of men. Although radical prostatectomy is cur...vekri
who were age 75 to 82 at the date of starting the therapy. Data was taken from the British Columbia Cancer Registry, which records all cancer diagnoses and treatments in the province of British Columbia (BC), Canada [4,5]. Mortality was determined from death certificates recorded ...
Postoperative function following radical surgery in gastric and colorectal cancer patients over 80 years of age: An objection to "ageism" PURPOSE: With rapid growth in the elderly population, the number of elderly cancer patients who should be offered life-prolonging radical surgery has been ... ...
Over the past two decades, serum PSA screening has provided a valuable tool for prostate cancer surveillance, however the age-adjusted incidence of mortality has remained relatively constant, therefore new tools are needed to guide prognosis and treatment. Research into the genetic origins of prostate...
What Is Prostate Cancer? Prostate canceris a malignant tumor of the prostate. The disease is less common before age 50, and experts believe that most elderly men have traces of it. African American men are more likely to getprostate cancerand have the highest death rate. Other than skin can...
This resource provides expert advice about prostate cancer to help you discuss key issues with your healthcare provider. Learn the facts about risk factors, symptoms, screening, diagnosis, and treatment through easy-to-understand animations, expert video
6 Although the libido declines with age, sexual activity is common among 70-, 80-, and even 90-year-old men.7 Given that sexual activity is common, including in older men,6,7 and that prostate cancer risk is high,8 any association between these factors would have clinical and public ...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relatives. There are various guidelines and consensus stat...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th
Prostate cancer alters cellular metabolism through events potentially preceding cancer morphological formation. Magnetic resonance spectroscopy (MRS)-based metabolomics of histologically-benign tissues from cancerous prostates can predict disease aggress